CD4 and tuberculosis: Together with its high sensitivity for TB diagnosis in people living with HIV (19) (sensitivity of 70.7% across CD4 strata), the FujiLAM might have considerable impact on the TB epidemic when scaled-up widely for use in near-patient settings.